Report: Manufacturers of costly drugs in Md. spend more on advertising, executives’ salaries than research
Md. drug affordability board approves framework for evaluating which drugs may be eligible for lower prices
Report: Manufacturers of costly drugs in Md. spend more on advertising, executives’ salaries than research
Md. drug affordability board approves framework for evaluating which drugs may be eligible for lower prices